Cargando…
A Phase 2b Clinical Trial Assessing Lomecel-B Infusion in Individuals with Aging Frailty: Study Design and Rationale
Frailty is a common and important geriatric syndrome characterized by age-associated declines in physiology and function across multiple organ systems, which lead to increased vulnerability to adverse health outcomes. A biological mechanism that underlies the decline in physical function associated...
Autores principales: | Ramdas, Kevin, Hitchinson, Ben, McClain-Moss, Lisa, Yousefi, Keyvan, Diaz, Liliana, Ruiz, Jorge, Hare, Joshua, Oliva, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8680528/ http://dx.doi.org/10.1093/geroni/igab046.2522 |
Ejemplares similares
-
A Phase I Trial Assessing Lomecel-B Infusion in Individuals with Alzheimer’s Disease: Study Design and Rationale
por: Ramdas, Kevin, et al.
Publicado: (2021) -
BLOOD-BASED BIOMARKER CHANGES IN A PHASE 2B TRIAL ASSESSING LOMECEL-B IN OLDER ADULTS WITH FRAILTY
por: Ramdas, Kevin, et al.
Publicado: (2022) -
Results and insights from a phase I clinical trial of Lomecel‐B for Alzheimer's disease
por: Brody, Mark, et al.
Publicado: (2022) -
Intramyocardial cell-based therapy with Lomecel-B during bidirectional cavopulmonary anastomosis for hypoplastic left heart syndrome: the ELPIS phase I trial
por: Kaushal, Sunjay, et al.
Publicado: (2023) -
Allogeneic mesenchymal stem cell therapy: A regenerative medicine approach to geroscience
por: Oliva, Anthony A., et al.
Publicado: (2019)